TABLE 2.
T-fusion nomenclature
| Fusion | Tat portion/fusion partner(s) | Tag(s) used |
|---|---|---|
| T-BIV | HIV-1 Tat AD/BIV Tat RBD | HA |
| T-SF1 | HIV-1 Tat AD/splicing factor 1 | HA |
| T-U2AF65 | HIV-1 Tat AD/U2AF65 | HA, GFP |
| T(K41A)-U2AF65 | HIV-1 Tat AD K41A/U2AF65 | HA, GFP |
| T-U2AF65ΔRS | HIV-1 Tat AD/U2AF65ΔRS domain | GFP |
| Tat-U2AF65 | HIV-1 Tat/U2AF65 | HA |
| T | HIV-1 Tat AD/no fusion | GFP |
| T-Rev | HIV-1 Tat AD/HIV-1 Rev RBD (residues 2-73) | HA, GFP |
| T-NLS | HIV-1 Tat AD/SV40 T-Ag NLS | GFP, HF |
| T-RS | HIV-1 Tat AD/U2AF65 RS domain | HA, GFP, HF |
| T(K41A)-RS | HIV-1 Tat AD K41A/U2AF65 RS domain | HA, GFP |
| T-MS2cp | HIV-1 Tat AD/MS2 coat protein | HA |
| T-U2AF35 | HIV-1 Tat AD/U2AF35 | HA |
| T-RS25-63 | HIV-1 Tat AD/U2AF65 RS dipeptides of residues 25-63 | HA |
| T-RE | HIV-1 Tat AD/U2AF65 RS dipeptides of residues 25-63 mutated to RE | HA |
| T-RG | HIV-1 Tat AD/U2AF65 RS dipeptides of residues 25-63 mutated to RG | HA |
| T-GS | HIV-1 Tat AD/U2AF65 RS dipeptides of residues 25-63 mutated to GS | HA |
| T-BIV-U2AF65 | HIV-1 Tat AD/BIV Tat RBD and U2AF65 |